The benzim idazole nucleoside are considerably m ore resistant to acid hydrolysis than the cor responding purine nucleosides. The effects o f halogenation on the ultraviolet absorption spectra o f the benzim idazole nucleosides are described.
Introduction
The biological properties of halogenated benzimi dazole nucleosides [1] have taken on added signifi cance in the light of the demonstration that 5,6-dichloro-l-/?-D-ribofuranosylbenzimidazole (DRB) is a selective and reversible inhibitor of hnRNA pro duction in mammalian cells [2, 3 a, 3 b] , reviewed in ref. [4] . Under appropriate conditions DRB also leads to a marked enhancement of interferon pro duction in mammalian cells [2, 3 a, 3 b] , reviewed in ref. [4] , Under appropriate conditions DRB also ical properties of this class of analogues are their antiviral and cytotoxic activities, exhibited also to an appreciable extent by the a-anomers of some benzi midazole nucleosides [4] , It is of interest in this con nection that 5,6-dimethyl-1-a-D-ribofuranosylbenzimidazole is a constituent of vitamin B12.
As the initial part of a program to study the antimetabolic properties of new benzimidazole and halogenated benzimidazole nucleosides, we report here on the preparation of the a-D-arabinofuranosyl nucleosides of benzimidazole and 5,6-dichlorobenzi- [5, 6] . The desirability of a simple procedure for preparation of the bromo derivatives is underlined by the fact that bromo derivatives of some benzimidazole nucleosides are as active, in some instances even more so, than the corresponding chloro derivatives [4] .
Results and Discussion
The 1-a-D-arabinofuranosides of benzimidazole and 5,6-dichlorobenzimidazole were prepared essen tially according to the general procedure of Niedballa and Vorbrüggen [7] . The trimethylsilyl deriva tive of the appropriate benzimidazole was con densed in the presence of SnCl4 with 1-O-methyl-2,3,5-tribenzoyl-a-D-arabinofuranose. The resulting benzoylated nucleosides were purified by chromato graphy on silica gel, and debenzoylated by treatment with NaOCH3 in methanol to give the free nucleo-sides, which were crystallized from aqueous ethanol (for the benzimidazole nucleoside), or water (for the 5,6-dichloro derivative). Identification was based on elementary analysis, NMR spectroscopy and UV spectrum. The same procedure was followed for the synthesis of l-/?-D-ribofuranosylbenzimidazole.
The monobromo and or/Ao-5,6-dibromo deriva tives of the benzimidazole nucleosides were then obtained by direct treatment with bromine water in aqueous medium. In the case of l-/?-D-ribofuranosylbenzimidazole, the initial product of the reaction was an approximately equimolar mixture of the 5-and 6-monobromo derivatives, as shown by analysis of the *H NMR spectrum (see below). By contrast, the initial product in the case of 1-a-D-arabinofuranosylimidazole appeared to be the 5-or 6-mono bromo derivative; in this case it did not prove feasible with the aid of NMR spectroscopy to establish unequivocally the position of bromination (see below).
Further prolonged treatment with bromine water led, for both nucleosides systems, to appearance of the 5,6-dibromo derivatives. The products were all identified on the basis of elementary analyses, X H NMR spectroscopy, as well as by acid hydrolysis to release the aglycone. In the case of the dibromo derivatives, this led to release of dibromobenzimidazole, identical with an authentic sample obtained according to Weygand et al. [8] , It is of interest that the benzimidazole nucleosides were much more stable in acid than purine nucleosides, e. g. under conditions where the latter undergo complete hy drolysis, the former exhibit only traces of hydrolysis products.
Bromination consequently proceeds stepwise as illustrated in Scheme 1. These results are reminiscent of those reported by Büchel [9] for bromination of 2- trifluorobenzimidazole, where the initial products are the 5(6)-monobromo derivatives. Somewhat dif ferent results were reported by Dandegonker and Shastri [10] for bromination of 2-methylbenzimidazole, the order of bromination being the 5-monobromo, followed by 5,7 [4, 6] ; the evidence for this latter result is, however, rather weak. Fractionation of the mono-and dibromo deriva tives was considerably facilitated with the aid of Servachrom (Heidelberg, GFR) XAD-4, hitherto profited from mainly with lipidic compounds. The potential use of this resin for fractionation of nucleic acid derivatives was pointed out by Zaika [11] and Uematsu and Suhadolnik [12] . It very effectively separated the monobromo and dibromo nucleosides of benzimidazole, the latter of which are more lipophilic. However, it did not prove feasible in this way to separate the isomeric monobromo nucleo sides. Attempts to separate these by fractional crys tallization were equally unsuccesful.
The ultraviolet absorption spectra of the brominated nucleosides exhibit certain regularities with respect to the parent compound ( Fig. 1 and Table I ). Introduction of a bromine atom leads to a bathochromic shift of the long-wavelength absorption bands, both for the neutral and cationic forms. Furthermore the spectra of the 5,6-dichloro and 5,6-dibromo nucleosides are quite similar, the latter being shifted somewhat bathochromically relative to the former.
1H N M R analyses
Final identification of the various products was achieved with the aid of *H NMR spectroscopy. The appropriate data for the chemical shifts and vicinal coupling constants of the base protons of benzimidazole, 5,6-dibromobenzimidazole, and the various nucleosides are listed in Table II . Analysis of the signals of the various protons, and the changes in chemical shifts resulting from bromination, permit ted of complete assignments of the individual proton signals and the position(s) of attachment of bromine in the benzimidazole ribosides: the initial product(s) of bromination are the 5-bromo and 6-bromo deriv atives, which crystallizes as a 1:1 mixture; the second bromine then adds ortho to the first, so that the Final unique product is the 5,6-dibromo deriv ative. By contrast, the initial product in the case of the arabinoside is the 5-bromo or 6-bromo de rivative, and the final product the 5,6-dibromo as for the riboside.
The monobromo derivative of the /?-riboside exhib its two pairs of signals characteristic for bromine substitution at C(5) and C (6) . Each of these consists of two singlets and two coupled AB doublets, with coupling constants of about 8.5 Hz. One of these cor responds to the 5-bromo derivative, the other to the 6-bromo. The most highly shielded singlets, located close to each other, originate from the H(2) proton of each monobromo derivative. The coupled doublets correspond to the protons H(6) and H (7) in the 5-bromo derivative, and the H (4) and H (5) in the 6-bromo analogue. The non-coupled (or very weakly coupled) singlets at 7.85 ppm and 8.07 ppm correspond to protons separated by four bonds, H (4) in the 5-bromo derivative and H (7) in the 6-bromo derivative.
By contrast, the monobromo derivative of the aarabinoside exhibits only one set of signals, corre sponding to either the 5-bromo or 6-bromo, with other possibilities excluded. The product of further bromination exhibits three singlets, as in the case of the /?-riboside (see Table II ), hence must be the 5,6-dibromo derivative. Assignment of the signals for the individual base fluence of the bromine substituents must be due to protons was provided by the effects of step-wise the presence of the sugar moiety, it is to be expected addition of bromine. The benzimidazole ring system that this would be reflected by those protons closest in both the /?-riboside and the a-arabinoside pos-to the sugar ring, i. e. H (7) and, possibly, H (6). The sesses symmetry close to that of the free base, which most deshielded proton in the dibromo derivative is is in the tautomeric equilibrium N (1)-H ^ N (3)-H consequently H(7). Analysis of all the different pos- [13] . Introduction of a bromine substituent should sible assignments of signals in the spectra of the free lead to similar changes in chemical shifts of protons base, and the monobromo and dibromo derivatives similarly located relative to the bromine. From of the nucleosides, demonstrated that the most closely Table II it will be noted that, in the fully symmetrical similar effects of bromine substitution on identically free base, two bromine substituents together result in located protons in all the compounds corresponded an identical change in shifts of H(4) and H (7), i. e. to the assignments given in Table II . Since the condeshielding by 0.4 ppm. A similar situation prevails sistency of these results did not depend on whether for the a-arabinoside, where the deshieldings are the bromine substituent in the monobromo deriva-0.40 ppm for H (4) and 0.44 ppm for H (7) . There is tive of the a-arabinoside was at C (5) or C (6), it is some departure from symmetry in the case of the ß-not possible to state at this time which of these is the riboside, where dibromination leads to deshielding product of monobromination. of one proton by 0.43 ppm as for the a-arabinoside,
The signals of the sugar protons of all the nucleoand of the other by as much as 0.62 ppm. Since any side products were fully consistent with those ex departures from the symmetrical nature of the in-pected. A detailed investigation of the conformations of these nucleosides requires, amongst others, syn thesis of appropriate 2-substituted analogues which are constrained to the syn conformation. Such an in vestigation is now under way. Some data on the solution conformation of l-/?-D-ribofuranosylimidazole itself have been reported by Lüdemann et al. [14] .
Experimental
1 -0-acetyl-2,3,5-tri-0-benzoylribofuranose was obtained from Pharma Waldhof (Düsseldorf, GFR) and l-0-methyl-2,3,5-tri-0-benzoylarabinofuranose was prepared by the method of Fletcher [15] , Melting points (uncorr.) were measured on a Boetius microscope hot stage. UV spectra were run on a Zeiss (Jena, GDR) VSU-2 spectrophotometer. Elementary microanalyses were performed on a Perkin-Elmer Model 240 instrument by Miss I. Celler of the Institute of Organic Chemistry.
*H NMR spectra were recorded on a JEOL JNM-4H-100 instrument, at concentrations of about 0.2 M in DMSO-d6. Chemical shifts, vs internal TMS, are accurate to ± 0.01 ppm and, in the case of simulated spectra, to ± 0.002 ppm. Coupling constants were determined to an accuracy of ± 0.2 Hz. For accurate determinations of the NMR parameters of more complex systems of the type AA'MM'X (benzimidazole base) and ABMNX (benzimidazole riboside), simulation of spectra was carried out for different initial values of the parameters with the aid of the non-iterative program LAOCOON III. Initial ap proximate values of the parameters were based on a first-order analysis of the system AA'MM'X for the benzimidazole protons. The locations of the signals in the simulated spectra did not differ from those in the recorded spectra by more than 0.002 ppm.
l-a-D-arabinofuranosylbenzimidazole: To 4.4 gm (23 mmol) of 1-trimethylsilylbenzimidazole in 50 ml of 1,2-dichloroethane was added 10.5 gm (~ 22mmol) 1 -0-methyl-2,3,5-tribenzoyl-a-D-arabinofuranose in 20 ml of 1,2-dichloroethane, followed by about 2.5 ml (~ 22 mmol) of freshly distilled SnCl4. The mixture was heated under reflux, with maintenance of an hydrous conditions, for 30 min, then cooled and diluted with 60 ml 1,2-dichloroethane. The mixture was vigorously shaken with a saturated solution of N aH C 03 and passed through a Celite pad. The organic phase was dried with anhydrous N a2S 0 4 and brought to dryness under reduced pressure. The resulting syrupy residue was dissolved in 20 ml methanol containing 1.25 g sodium methoxylate. After 4 h, the solution was brought to neutrality with HC1 and deposited on a 35 x 4 cm column of A120 3 previously equilibrated with EtOH. The column was eluted with ethanol (500 ml) and then with 2 litres of EtOH-HzO (1 :1 , v/v), with collection of 25-ml frac tions. The fractions containing the nucleoside (15 to 45) were combined, brought to dryness under re duced pressure and the residue crystallized from aqueous ethanol to yield 1.01 g (18%) of microscopic needles, m.p. 228.5-229.5 °C. Elem. anal.: C, 57.29%; H, 11.20%; N, 5.56%. Calcd. for C12H140 4N 2: C, 57.60%; H, 11.20%; N, 5.60%. To 6.5 g (25 mmol) of l-trimethylsilyl-5,6-dichlorobenzimidazole in 50 ml of 1,2-dichloroethane was added 12.9 g (~ 27 mmol) l-0-methyl-2,3,5-tribenzoyl-a-D-arabinofuranose in 50 ml 1,2-dichloroethane, followed by 2.5 ml SnCl4. After 6 h at room temperature, only about 5% of the starting substance had reacted. A total of 6 ml SnCl4 was then added portionwise at intervals of 2 h. After 26 h the mix ture was heated under reflux for 15 min, then cooled and further worked up as for 1-a-D-arabinofuranosylbenzimidazole, above. The resulting syrupy product was applied to a 40 x 5 cm column of silica gel and eluted with benzene (300 ml), benzeneacetone (99 : 1, v/v, 500 ml), benzene-acetone (98:2, 500 ml), benzene-acetone (97:3, 500 ml) and ben zene-acetone (96:4, 500 ml). The nucleoside was eluted from the column with 400 ml of 5% acetone in benzene. Following removal of solvent, the syrupy residue was dissolved in 60 ml ethanol containing 656 mg sodium ethoxylate, heated for 2 h at 60 °C, cooled and brought to neutrality with HC1. The solu tion was brought to dryness, taken up in water and again brought to dryness. This was repeated several times. The residue was then crystallized from aqueous ethanol (2.5 g), and recrystallized from water in the form of needles (2. To 200 mg (0.8 mmol) of 1-a-D-arabinofuranosylbenzimidazole and 250 mg K2H P 0 4, dissolved by heating in 30 ml water, was added 13 ml bromine water over a period of 30 min. Stirring was con tinued for 30 min, and the mixture applied to a 35 x 2 cm column of Amberlite XAD-4. Elution was carried out with a gradient of water and 50% isopropanol (2 litres To 200 mg (0.8 mmol) 1-a-D-arabinofuranosylbenzimidazole in 25 ml water was added, over a period of 1 h, 30 ml bromine water. Stirring was con tinued for 4 h at room temperature. The mixture was treated with charcoal, filtered and the filtrate brought to pH 8, and applied to a 35 x 2 cm column of Amberlite XAD-4. Elution was with a gradient of water and 50% isopropanol (2 litres). The dibromonucleoside eluted in the range 45 -50% isopropanol. To 260 mg (1.04 mmol) l-/?-D-ribofuranosylbenzimidazole in 20 ml H zO was added, during the course of 1 h, 35 ml bromine water and the mixture stirred for an additional 3 h. It was then treated with activated charcoal, filtered, and the filtrate brought to pH 8 with NH 4OH, applied to a 35 x 2 cm column of Amberlite XAD-4, and elution carried out with a linear gradient of water and 50% isopropanol (2 li tres). The major peak (45-50% isopropanol) was brought to dryness and crystallized from 50% aque ous ethanol to yield 245 mg (59%) in the form of parallelopipeds, m. p. 186 °C. Elem. anal.: C, 34.47%; H, 3.09% N, 6.76%. Calcd. for C12H 12N 20 4Br • 0.5 H20: C, 34.53%; H, 3.12%; N, 6.71%.
Acid hydrolysis: A solution of 10 mg of the forego ing product in 3 ml 6 n HC1 was heated on a water bath for 10 h, then brought to dryness and the residue taken up in a small volume of 50% methanol. This was brought to pH 8 with NH 4OH and sub jected to thin-layer chromatography on silica gel HF254 with the solvent system chloroform-methanol (9:1). The chromatogram showed only one spot identical chromatographically (RF = 0.70) and spec trally with 5,6-dibromobenzimidazole as reported by Weygand et al. [8] .
